Supernus Pharmaceuticals, Inc. · NASDAQ:SUPN
Vanguard Portfolio Management LLC reported a 5.66% stake in Supernus Pharmaceuticals, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
Vanguard Portfolio Management LLC reported a 5.66% stake in Supernus Pharmaceuticals, Inc., 3,263,309 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.66%
- Shares
- 3,263,309
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Portfolio Management | 5.66% | 3,263,309 |